#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Carcinoid tumour Central nervous system neoplasm Hepatic angiosarcoma Cervix carcinoma recurrent Cerebral arteriovenous malformation haemorrhagic Spinal cord injury cervical Mixed-type liposarcoma Uveitis Polyneuropathy Prophylaxis against transplant rejection Insulinoma Hyperinsulinaemic hypoglycaemia Polymyositis Oesophageal squamous cell carcinoma stage II Extra-osseous Ewing's sarcoma recurrent More trials…

    Learn about Rare Diseases

    Prolymphocytic leukaemia Antisynthetase syndrome – Trials in Disease Acute respiratory distress syndrome – Trials in Disease Rhabdoid tumour – Basic Information Breast angiosarcoma metastatic – Basic Information Vascular malformation Bronchopulmonary dysplasia – Basic Information Immunodeficiency congenital – Basic Information Hereditary neuropathic amyloidosis – Trials in Disease Glycogen storage disease type I More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Gsk4011499 Quizartinib Dihydrochloride Isosorbide Dinitrate Cilazapril Revumenib Iopromide Goserelin Quavonlimab Tisotumab Vedotin Reparixin Fludarabine Phosphate Ph. Eur. Secale Cereale Encaleret Sulfate Varegacestat Chlorhexidine Dihydrochloride Tadekinig Alfa LY3372993 Valiltramiprosate Wt1/Il15/Il15Ra Mrna Dc Frexalimab More therapies…

    Learn about Your Condition

    Tubulointerstitial nephritis Pleomorphic leiomyosarcoma Hypoglycaemia Pruritus Actinic keratosis Stem cell transplant HER2 protein overexpression Benign renal neoplasm Burning mouth syndrome Hand dermatitis Loeys-Dietz syndrome Langerhans cell sarcoma Developmental hip dysplasia EGFR gene mutation Adrenoleukodystrophy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Endometrial cancer

  • Study on Olaparib and Bevacizumab for Patients with Advanced Ovarian, Fallopian Tube, or Peritoneal Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Retroperitoneal cancer
    • Endometrial cancer
    • Fallopian tube cancer
    Investigated Drugs:
    • Bevacizumab
    • Olaparib
    Spain

  • Study on the Safety and Effects of Farletuzumab Ecteribulin for Patients with Ovarian, Breast, Endometrial, and Lung Cancer

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Endometrial cancer
    • Ovarian cancer
    • Triple negative breast cancer
    Investigated Drugs:
    • Farletuzumab Ecteribulin
    • Lenvatinib
    France Spain

  • Study of E7386 and Lenvatinib for Patients with Liver, Colon, Endometrial, or Other Solid Tumors

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Endometrial cancer
    • Hepatocellular carcinoma
    • Colorectal cancer
    Investigated Drugs:
    • (6S,9As)-8-((6-(3-(4-Ethyl-1-Piperazinyl)-1-Azetidinyl)-2-Pyridinyl)Methyl)-6-((2-Fluoro-4-Hydroxyphenyl)Methyl)Hexahydro-4,7-Dioxo-N-(Phenylmethyl)-2-(2-Propen-1-Yl)-2H-Pyrazino(2,1-C)(1,2,4)Triazine-1(6H)-Carboxamide
    • Doxorubicin Hydrochloride
    • Lenvatinib
    Denmark France Italy Spain

  • Study of Tulmimetostat (CPI-0209) for Patients with Advanced Solid Tumors and Lymphomas

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Mesothelioma malignant
    • Lymphoma
    • Endometrial cancer
    Investigated Drugs:
    • Tulmimetostat
    • Enzalutamide
    France Italy Poland Spain

  • Study of PC14586 for Patients with Advanced Solid Tumors with a Specific TP53 Mutation

    Recruiting

    2 1 1
    Investigated Diseases:
    • Lung neoplasm malignant
    • Endometrial cancer
    • Ovarian cancer
    Investigated Drugs:
    • Pc14586
    France Germany Italy Spain

  • Study of AZD9574 and Temozolomide for Patients with Advanced Solid Tumors, Including Breast, Ovarian, Pancreatic, and Prostate Cancers

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Metastases to biliary tract
    • Metastases to central nervous system
    • Metastatic glioma
    Investigated Drugs:
    • 6-Fluoro-5-[4-[(5-Fluoro-2-Methyl-3-Oxo-4H-Quinoxalin-6-Yl)Methyl]Piperazin-1-Yl]-N-Methylpyridine-2-Carboxamide
    • [11C]Az14193391
    • Temozolomide
    Spain Sweden
Previous Page
1 2 3 4 5 6 … 9
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!